ANZ1001 SORBET: Study of Oestrogen Receptor Beta and Efficacy of Tamoxifen—A single-arm, phase II study of the efficacy of tamoxifen in triple-negative but estrogen receptor beta-positive metastatic breast cancer.
B. E. Kiely
No relevant relationships to disclose
K. Phillips
No relevant relationships to disclose
P. A. Francis
No relevant relationships to disclose
F. M. Boyle
No relevant relationships to disclose
J. F. Forbes
No relevant relationships to disclose
S. B. Fox
No relevant relationships to disclose
L. Murphy
No relevant relationships to disclose
V. Gebski
No relevant relationships to disclose
D. F. Lindsay
No relevant relationships to disclose
R. L. Sutherland
No relevant relationships to disclose
H. Badger
No relevant relationships to disclose